Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Acquisition

7 Oct 2021 15:23

RNS Number : 4085O
Galliford Try Holdings PLC
07 October 2021
 

The information contained within this Announcement constitutes inside information. Upon the publication of this Announcement via A Regulatory Information Service, this inside information is now considered to be in the public domain.

 

FOR IMMEDIATE RELEASE.

 

7 October 2021

 

Galliford Try Holdings plc ("Galliford Try")

 

Acquisition of nmcn's Water business from nmcn plc (in administration) ("nmcn") and nmcn Sustainable Solutions Limited (in administration)

 

The Board of Galliford Try is pleased to announce that it has agreed to acquire substantially all of nmcn's Water business including the specialist water process and control businesses Nomenca and Lintott (together, "nmcn Water" or the "Water Business") for an aggregate consideration of £1.0 million in cash (the "Transaction").

 

Commenting on the Transaction, Bill Hocking, Chief Executive of Galliford Try, said:

"I am delighted to welcome the employees, clients and suppliers of nmcn Water to Galliford Try. This acquisition is an excellent strategic fit with our existing business and will accelerate the growth of our successful Environment division, providing work with new clients and increasing our capabilities. This is a very exciting time as we deliver our Sustainable Growth Strategy and I look forward to a bright future for our collective team."

 

 

nmcn Water profile and fit with Galliford Try

 

nmcn Water works with UK water utility companies to build and maintain high-quality water and wastewater treatment systems. Its geographic coverage, customer relationships and technical capabilities are all highly complementary to Galliford Try's existing operations.

 

Galliford Try has a detailed understanding of nmcn Water's operations and has closely followed the evolution of the Water Business through nmcn's refinancing process and various trading and financial disclosures through 2021. In combination, this knowledge has provided us with a thorough understanding of nmcn Water and its prospects.

 

The 75 year heritage and values of nmcn Water are an excellent fit with the history and values of Galliford Try. In particular, the Transaction is consistent with our recently published Sustainable Growth Strategy:

 

· Providing a geographic footprint that will accelerate growth of the Water Business through a series of established frameworks with new customers for Galliford Try;

· Extending our capabilities in the design and Mechanical, Electrical, Instrumentation, Control and Automation (MEICA) elements of the Water Business; and

· Introducing further high quality people to strengthen our own talent pool.

 

Galliford Try is especially appreciative of the efforts of nmcn's customers, suppliers, employees and management over the last year and will be engaging proactively to provide the stability to move forward. Approximately 900 nmcn Water employees will join Galliford Try as a result of the Transaction, including its senior management team.

 

Details of the Transaction

 

Galliford Try will acquire substantially all of nmcn's Water Business, including the specialist water process and control businesses Nomenca and Lintott. The Water Business generates annual revenue of approximately £100 million and the Transaction is expected to be immediately earnings enhancing, before transaction and restructuring costs. The Transaction has been implemented by way of an administration sale.

 

In addition to the £1.0 million purchase price, Galliford Try anticipates that it will have to fund certain contractual liabilities incurred prior to the completion date of the Transaction which will be necessary to provide operational stability to the Water Business.

 

For the year ended 31 December 2019, being the last year for which nmcn has published audited results, nmcn's water segment, prior to subsequent re-statements, generated operating profit of £7.6 million on turnover of £282.6 million. The gross assets of nmcn's water segment were £70.0 million as at 31 December 2019.

 

 

The person responsible for arranging the release of this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel & Company Secretary.

 

- End -

 

For further information please contact:

 

Galliford Try Holdings plc

Bill Hocking, Chief Executive

Andrew Duxbury, Finance Director

Kevin Corbett, General Counsel & Company Secretary

Tel: +44 (0)18 9585 5001

 

Peel Hunt LLP (Financial Adviser and Corporate Broker)

Charlie Batten

Harry Nicholas

Miles Cox

 

 

 Tel: +44 (0)20 7418 8900

Tulchan Communications

James Macey White

Victoria Boxall

Tel: +44 (0)20 7353 4200

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQMRBITMTBMBPB
Date   Source Headline
1st Jun 202610:00 amRNSTotal Voting Rights
29th May 202610:45 amRNSHolding(s) in Company
28th May 20264:10 pmRNSHolding(s) in Company
19th May 20264:00 pmRNSHolding(s) in Company
7th May 20267:00 amRNSInvestor and Analyst Site Visit
1st May 202610:00 amRNSTotal Voting Rights
23rd Apr 202610:30 amRNSReplacement: Completion of Share Buyback Programme
22nd Apr 20267:10 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20264:25 pmRNSContract
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20264:15 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20262:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 202610:00 amRNSDirector/PDMR Shareholding
4th Mar 20263:00 pmRNSReplacement - Transaction in Own Shares
4th Mar 20267:00 amRNSHalf-year Financial Report
2nd Mar 202610:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSContract
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202610:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:02 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.